{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:15:13Z","timestamp":1783498513910,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative depressive symptoms may impair recovery and quality of life in patients undergoing breast cancer surgery. Esketamine has shown potential antidepressant and analgesic effects in the perioperative setting. This meta-analysis evaluated the efficacy and safety of perioperative esketamine for postoperative depressive symptoms in patients undergoing breast cancer surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Cochrane Library, Web of Science, CNKI, and WanFang were systematically searched from database inception to 18 May 2026. Randomized controlled trials comparing perioperative esketamine with control interventions in patients undergoing breast cancer surgery were included. The primary outcome was postoperative depressive symptom score. Secondary outcomes included postoperative pain scores and adverse events. Random-effects models were used as the primary analytical approach. Risk of bias and certainty of evidence were assessed using the RoB 2 tool and the GRADE approach, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen randomized controlled trials involving 1,515 patients were included. Perioperative esketamine was associated with significantly lower postoperative depressive symptom scores at postoperative day 1 (SMD = \u22120.78, 95% CI: \u22121.08 to \u22120.48), postoperative day 3 or 48\u201372\u00a0h (SMD = \u22121.07, 95% CI: \u22121.63 to \u22120.51), postoperative day 7 (SMD = \u22120.79, 95% CI: \u22121.10 to \u22120.49), and long-term follow-up (SMD = \u22121.16, 95% CI: \u22121.68 to \u22120.64). For postoperative pain, esketamine was associated with lower postoperative pain scores at postoperative day 1 or 24\u00a0h (MD = \u22120.66, 95% CI: \u22121.11 to \u22120.21) and postoperative day 3 or 48\u201372\u00a0h (MD = \u22120.66, 95% CI: \u22121.09 to \u22120.23), but not at postoperative day 7. However, substantial heterogeneity and wide prediction intervals were observed for pain outcomes. The incidences of nausea and vomiting, postoperative delirium, and dizziness did not differ significantly between the esketamine and control groups. The certainty of evidence ranged from low to very low across outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Perioperative esketamine may reduce postoperative depressive symptom scores and provide short-term analgesic benefits in patients undergoing breast cancer surgery. However, substantial heterogeneity, methodological limitations, and low to very low certainty of evidence warrant cautious interpretation. Further high-quality randomized trials are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD420251173178<\/jats:ext-link>\n                      , identifier CRD420251173178.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1806943","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:35:17Z","timestamp":1783496117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of perioperative esketamine for postoperative depressive symptoms in breast cancer patients: a meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Ruoyi","family":"Ji","sequence":"first","affiliation":[{"name":"School of Psychology and Cognitive Sciences, Peking University","place":["Beijing, China"]},{"name":"School of Psychology, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Anesthesiology, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical Imaging College, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Weifang People\u2019s Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Anesthesiology, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Anesthesiology, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Weifang People\u2019s Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Breast Disease Center, Weifang People\u2019s Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanceng","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Weifang People\u2019s Hospital","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/Nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/S12871-023-02135-8","article-title":"Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Anesthesiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00213-024-06673-y","article-title":"Optimizing esketamine administration for postoperative depression: a comprehensive study on laparoscopic bariatric surgery patients","volume":"242","author":"Dai","year":"2025","journal-title":"Psychopharmacol. Berl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3760\/cma.j.cn.115807-20231123-00163","article-title":"Effects of esketamine on early postoperative recovery and cognitive function after modified radical mastectomy for breast cancer in elderly patients","volume":"18","author":"Ding","year":"2024","journal-title":"Chin. J. Endocr. Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12893-016-0120-y","article-title":"Depression and postoperative complications: an overview","volume":"16","author":"Ghoneim","year":"2016","journal-title":"BMC Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1016\/j.clbc.2024.06.003","article-title":"S-ketamine infusion on chronic postoperative pain following breast cancer surgery: a randomized double-blind placebo-controlled trial","volume":"24","author":"Guo","year":"2024","journal-title":"Clin. Breast Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.13705\/j.issn.1671-6825.2024.04.070","article-title":"Effect of esketamine on modified radical mastectomy for breast cancer patients with mild to moderate depression","volume":"60","author":"He","year":"2025","journal-title":"J. Zhengzhou Univ. Med. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/S12871-025-02908-3","article-title":"Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial","volume":"25","author":"Hou","year":"2025","journal-title":"BMC Anesthesiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.11969\/j.issn.1673-548X.2024.01.020","article-title":"Effect of intraoperative intravenous injection of different doses of esketamine on postoperative anxiety and depression in breast cancer patients","volume":"53","author":"Ji","year":"2024","journal-title":"J. Med. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0175395","DOI":"10.1371\/journal.pone.0175395","article-title":"Depression in breast cancer patients who have undergone mastectomy: a national cohort study","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3760\/cma.j.cn321761-20220630-00732","article-title":"Effect of esketamine for postoperative intravenous analgesia on pain, anxiety and depression in breast cancer patients","volume":"44","author":"Li","year":"2023","journal-title":"Int. J. Anesthesiol. Resusc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/08941939.2019.1710626","article-title":"Effect of pretreatment of S-Ketamine on postoperative depression for breast cancer patients","volume":"34","author":"Liu","year":"2021","journal-title":"J. Invest. Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12888-026-07837-0","article-title":"Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study","volume":"26","author":"Liu","year":"2026","journal-title":"BMC Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"103997","DOI":"10.1016\/j.ajp.2024.103997","article-title":"Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: a meta-analysis of randomized controlled trials","volume":"95","author":"Lou","year":"2024","journal-title":"Asian J. Psychiatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6918327","DOI":"10.1155\/2016\/6918327","article-title":"Efficacy of continuous S(+)-Ketamine infusion for postoperative pain control: a randomized placebo-controlled trial","volume":"2016","author":"Miziara","year":"2016","journal-title":"Anesthesiol. Res. Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3760\/cma.j.cn431274-20240129-00201","article-title":"Effect of esketamine combined with pectoral nerve block on anxiety and depression in patients undergoing general anesthesia for breast cancer surgery","volume":"26","author":"Pan","year":"2024","journal-title":"J. Chin. Physician"},{"key":"B20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1570159X21666230808111908","article-title":"Peripheral neuroinflammation and pain: how acute pain becomes chronic","volume":"22","author":"Schumacher","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2042098620937899","DOI":"10.1177\/2042098620937899","article-title":"Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review","volume":"11","author":"Salahudeen","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9685","DOI":"10.2147\/DDDT.S540781","article-title":"Effects of continuous perioperative esketamine infusion on postoperative depression in breast cancer patients: a randomized controlled double-blind trial","volume":"19","author":"Shen","year":"2025","journal-title":"Drug Des. Devel Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.21037\/ATM-22-2756","article-title":"The use of esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial","volume":"10","author":"Su","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bja.2020.04.088","article-title":"Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies","volume":"125","author":"Wang","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"B26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3969\/j.issn.1006-1959.2024.06.017","article-title":"Intervention of esketamine combined with serratus anterior and transversus thoracis muscle plane block on postoperative depression in breast cancer patients","volume":"37","author":"Wang","year":"","journal-title":"Med. Inf."},{"key":"B27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12888-024-05753-9","article-title":"Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial","volume":"24","author":"Wang","year":"","journal-title":"BMC Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3969\/j.issn.2095-8552.2026.04.027","article-title":"Intervention effect and safety evaluation of esketamine on perioperative depressive status in patients with breast cancer","volume":"54","author":"Wang","year":"2026","journal-title":"Chin. J. Clin."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e075767","DOI":"10.1136\/BMJopen-2023-075767","article-title":"Influence of low-dose esketamine on postoperative depressive symptoms in patients with breast cancer (EASE): study protocol for a randomised controlled trial","volume":"13","author":"Wei","year":"2023","journal-title":"BMJ Open"},{"key":"B30","doi-asserted-by":"publisher","first-page":"111821","DOI":"10.1016\/j.jclinane.2025.111821","article-title":"Effect of esketamine on postoperative depression in women with breast cancer and preoperative depressive symptoms: the EASE randomized trial","volume":"103","author":"Wei","year":"2025","journal-title":"J. Clin. Anesth."},{"key":"B31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.13479\/j.cnki.jip.2023.02.012","article-title":"Effect of subanesthetic dose of esketamine on postoperative patients with breast cancer","volume":"50","author":"Xu","year":"2023","journal-title":"J. Int. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12935-025-03664-7","article-title":"Esketamine reduces postoperative depression in breast cancer through TREK-1 channel inhibition and neurotransmitter modulation","volume":"25","author":"Xu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-025-09755-9","article-title":"Adenosine signalling drives antidepressant actions of ketamine and ECT","volume":"649","author":"Yue","year":"2026","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.2147\/JPR.S380354","article-title":"Effects of esketamine combined with ultrasound-guided pectoral nerve block type II on the quality of early postoperative recovery in patients undergoing a modified radical mastectomy for breast cancer: a randomized controlled trial","volume":"15","author":"Yu","year":"2022","journal-title":"J. Pain Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3760\/j.issn.1673-4777.2025.11.013","article-title":"Effects of esketamine on perioperative delirium and depression in patients with breast cancer","volume":"20","author":"Zhao","year":"2025","journal-title":"China Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.12289\/j.issn.1008-0392.21320","article-title":"Effect of subanesthetic dose of S-ketamine administration on postoperative depression and anxiety in breast cancer patients","volume":"43","author":"Zhu","year":"2022","journal-title":"J. Tongji Univ. Med. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1806943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:35:27Z","timestamp":1783496127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1806943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":38,"alternative-id":["10.3389\/fphar.2026.1806943"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1806943","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1806943"}}